Nathan Jones is an associate in Baker McKenzie's Mergers & Acquisitions practice and is based in London. Nathan primarily handles complex cross-border and domestic acquisitions, divestitures and restructurings specialising in the life sciences, technology and healthcare industries. Nathan also provides counsel regarding general corporate matters and corporate governance issues.
He completed a six-month secondment to GlaxoSmithKline plc in 2020 to assist with the legal integration of its world leading consumer healthcare business joint venture with Pfizer Inc.
Prior to joining Baker McKenzie, Nathan worked for a leading Australian law firm where he gained experience across a broad range of corporate transactions.
Representative Legal Matters
Assisted ScanSource Inc on the divestment of its European product hardware business to US family office, Ten Oaks Group.
Assisted GlaxoSmithKline plc on the legal closing and integration of over 50 delayed markets with respect to its consumer healthcare business joint venture with Pfizer Inc including a six month client secondment.
Assisted GlaxoSmithKline plc on the global closing of its USD 12.7 billion joint venture with Pfizer Inc. to combine their consumer healthcare businesses.
Assisted a US medical devices manufacturer group with the UK legal aspects of various global internal restructurings.
Advised private company clients on recent changes to the UK Corporate Governance laws, in particular the Wates Principles for Corporate Governance.
- New South Wales~Australia
- Macquarie University (Bachelor of Laws with Bachelor of Commerce)